AI-guided design of better mRNA sequences for vaccines
Optimizing mRNA sequences with deep neural networks
Researchers are using deep-learning tools to design improved mRNA sequences that could help vaccines and mRNA treatments work better against new COVID-19 variants.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11176878 on NIH RePORTER |
What this research studies
This project uses deep neural networks to find mRNA sequence features that improve stability and protein production, including changes in the 5' and 3' untranslated regions. Models will be trained on viral and vaccine sequence data and then used to propose optimized mRNA sequences targeting SARS-CoV-2 proteins. Promising designs will be tested in the lab to measure expression and immune-related signals such as antibody-target recognition. The aim is to create mRNA designs that keep vaccines effective as the virus mutates.
Who could benefit from this research
Good fit: Ideal participants for any human-related parts would be people willing to donate blood or enroll in future vaccine or immunogenicity studies, especially those at risk for COVID-19 or interested in variant-updated vaccines.
Not a fit: People seeking immediate treatment for an active COVID-19 infection would not receive direct or immediate benefit from this research.
Why it matters
Potential benefit: If successful, the work could produce mRNA designs that generate broader or stronger immune responses against current and future SARS-CoV-2 variants.
How similar studies have performed: Existing mRNA vaccines have shown real-world protection and early AI-driven sequence optimization has improved expression in lab settings, but applying deep neural networks specifically to keep COVID-19 mRNA vaccines effective against variants is a relatively new approach.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Zhou, Xiaobo — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Zhou, Xiaobo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.